IMI-JU-09-2013-01
IMI-JU-09-2013-01
1 project · €2,270,000 total EU contribution (project-level) · 19 participating organizations · 10 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€2,270,000
Countries active
Participant organizations by country (headquarters in CORDIS).
- BE (3)
- Netherlands (3)
- UK (3)
- France (2)
- SE (2)
- CH (1)
- Germany (1)
- HR (1)
- IE (1)
- TR (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- UNIVERSITAIR MEDISCH CENTRUM GRONINGEN1 projects · NL
- HALMED1 projects · HR
- AMGEN1 projects · BE
- ASTRAZENECA AB1 projects · SE
- Bayer Pharma AG1 projects · DE
- DH1 projects · UK
- Epidemico1 projects · IE
- EURORDIS - RARE DISEASES EUROPE1 projects · FR
- GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED1 projects · UK
- JANSSEN PHARMACEUTICA NV1 projects · BE
- NOVARTIS1 projects · CH
- SARD1 projects · FR
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Recognising Adverse Drug Reactions WEB-RADR · 115632 | FP7 | €2,270,000 | €5,940,396 | Details |